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Abstract
Objective To quantify the link between lower, subclinically symptomatic,
levels of psychological distress and cause-specific mortality in a large
scale, population based study.
Design Individual participant meta-analysis of 10 large prospective
cohort studies from the Health Survey for England. Baseline
psychological distress measured by the 12 item General Health
Questionnaire score, and mortality from death certification.
Participants 68 222 people from general population samples of adults
aged 35 years and over, free of cardiovascular disease and cancer, and
living in private households in England at study baseline.
Main outcome measures Death from all causes (n=8365),
cardiovascular disease including cerebrovascular disease (n=3382), all
cancers (n=2552), and deaths from external causes (n=386). Mean
follow-up was 8.2 years (standard deviation 3.5).
ResultsWe found a dose-response association between psychological
distress across the full range of severity and an increased risk of mortality
(age and sex adjusted hazard ratio for General Health Questionnaire
scores of 1-3 v score 0: 1.20, 95% confidence interval 1.13 to 1.27;
scores 4-6: 1.43, 1.31 to 1.56; and scores 7-12: 1.94, 1.66 to 2.26;
P<0.001 for trend). This association remained after adjustment for
somatic comorbidity plus behavioural and socioeconomic factors. A
similar association was found for cardiovascular disease deaths and
deaths from external causes. Cancer death was only associated with
psychological distress at higher levels.
Conclusions Psychological distress is associated with increased risk
of mortality from several major causes in a dose-response pattern. Risk
of mortality was raised even at lower levels of distress.
Introduction
A series of studies have shown an association between
symptoms of depression and anxiety (commonly referred to as
psychological distress) and an elevated risk of premature
mortality,1 2 cardiovascular disease,3-6 and potentially all cancers,7
although these are not universal observations.8 9 Prospective
studies investigating these associations have generally been
small in scale, with only two studies reporting more than 1000
disease events.10 11 Smaller studies lead to unreliable estimates
of risk, do not permit detailed investigation of the effect of
reverse causality, and hamper insights into the association across
the full range of psychological distress severity. Investigation
of the role of reverse causality—the possibility that the early
stages of disease (for example, chest pain) might cause
psychological distress—requires large numbers of participants
and events to have a sufficiently large sample after individuals
with existing illness or deaths in the early phases of follow-up
are excluded.
Furthermore, extant studies have been unable to adequately
examine whether a dose-response association exists between
distress and mortality. The increased mortality associated with
mental illness that is sufficiently severe to need admission to a
psychiatric hospital is well described.12However, if the influence
of psychological distress on mortality is occurring at levels
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lower that hitherto suggested—in people who would not come
to the attention of mental health practitioners—this may have
potentially important implications for treatment.
In view of these limitations of existing studies, we undertook
an individual participant meta-analysis of 10 large, community
based cohort studies of the role of psychological distress as a
risk factor for death from all causes, cardiovascular disease,
cancer, and external causes. In contrast to a literature based
meta-analysis, which may have to exclude studies not reporting
their results in an appropriate manner, the possibility of
publication bias is minimised in an individual participant
meta-analysis through close collaboration with data providers.
Furthermore, a literature based meta-analysis cannot provide
precise estimates of associations between risk markers and
disease, reliable information on the shape of a specific risk
factor-disease relation (for example, dose-response v threshold),
or a consistent approach to statistical control for plausible
covariates and subgroup analyses.While this approach has been
taken for physiological risk factors for mortality previously,13 14
the present study is the first such meta-analysis of psychological
distress.
Methods
Study samples
Participants were taken from the Health Survey for England,15 16
a representative health examination study sampling people from
the general population living in private households in that
country. From 1994 to 2004, 11 independent, cross sectional
studies with identical methodologies took place on an annual
basis. Consenting studymembers (75 936 (89.1%)) were linked
to National Health Service mortality data up to February 2008.
For this analysis, we used raw data from people aged 35 years
and over from all these study years, with the exception of 1996
when psychological distress was not measured. Ethical approval
was obtained from the London Research Ethics Council.
Measurement of psychological distress
During a household visit, interviewers collected information
using computer-assisted personal interviewing modules. We
measured psychological distress using the 12 item version of
the General Health Questionnaire (GHQ-12), a widely used
measure of distress in population studies.17 18 The GHQ-12 is
generally considered to be a unidimensional scale of
psychological distress,19 consisting of items capturing symptoms
of anxiety, depression, social dysfunction, and loss of
confidence. Study members respond to whether a symptom is
present by using a four point Likert scale (“not at all”=0, “same
as usual”=0, “more than usual”=1, “muchmore than usual”=1).
A total GHQ-12 score of four or greater leads to people being
defined as psychological distress “cases” and scores 0-3 as
“non-cases”; this definition has been validated against
standardised psychiatric interviews and has been strongly
associated with various psychological disorders such as
depression and anxiety.20 21 Most previous studies used such a
dichotomy and few have examined associations across the full
range of psychological distress. No standard cut-off values exist
for dividing up “cases” identified by a GHQ-12 score threshold.
We therefore chose to divide people into four groups based on
their GHQ-12 score: asymptomatic (score 0), subclinically
symptomatic (score 1-3), symptomatic (score 4-6), and highly
symptomatic (score 7-12).
Mortality data
Causes of death recorded on death certificates were coded using
the international classification of diseases, 9th and 10th revisions
(ICD-9 and ICD-10, respectively).We identified cardiovascular
disease deaths (including ischaemic heart disease,
cerebrovascular disease, peripheral vascular disease and heart
failure) using codes 410-414, 430-438, 440, 443-5, and 428
(ICD-9); and I20-I25, I50, I60-70, I73 and I74 (ICD-10). Cancer
deaths were identified using codes 140-239 (ICD-9) and
C00-D48 (ICD-10). We identified deaths from external causes
using codes 800-999 and E800-E999 (ICD-9) and S00-Y98
(ICD-10). For the main analyses, any mention of a condition
on the death certificate was counted but a subgroup analysis
restricted cases to those where the condition was the underlying
cause of death.
Statistical analyses
We ascertained that the proportional hazards assumption had
not been violated by inspecting the log(−log(survival)) plot.
We then used Cox proportional hazards models22 to compute
study-specific hazard ratios with accompanying 95% confidence
intervals for the association of GHQ-12 score with mortality
outcomes. Heterogeneity in the effect estimates between studies
was examined using the I2 statistic, which indicates the
proportion of the total variation in the estimates due to
between-studies variation. The I2 varied between 0% and 81.1%,
depending on the mortality outcome and psychological distress
variable used in the analysis. Owing to this heterogeneity, we
pooled the study-specific effect estimates and their standard
errors in random effects meta-analyses. Study members scoring
0 on the GHQ-12 were regarded as being free of psychological
distress and used as the reference group. We compared this
group with the three GHQ-12 score groups (scores 1-3, 4-6, and
7-12), and also reported the hazard ratio per one standard
deviation increment in GHQ-12 score (calculated with sex
specific standard deviations: men 2.41, women 2.75).
Days were the time scale and, for participants with no record
of an event, the data were censored at 15 February 2008.Models
were adjusted for age (years), sex, current occupational social
class (professional, managerial or technical, skilled non-manual,
skilled manual, partly skilled, and unskilled), body mass index,
systolic blood pressure (mm Hg), physical activity (any
moderate to vigorous physical activity in a week), smoking
status (not a current smoker; or <5, 5-10, 10-15, 15-20, and >20
cigarettes per day), alcohol consumption (units per week), and
diabetes at baseline (yes or no). Details on the measurement
protocols and data handling of these covariates can be found
elsewhere.16 23 We calculated the population proportional
attributable risk for each mortality outcome and the four
categories of GHQ-12 score using a standard equation.24
To further examine the association between crude GHQ-12
score and mortality (all cause, cardiovascular disease, cancer,
and external causes), we meta-analysed study specific Cox
proportional hazard models to calculate age and sex adjusted
hazard ratios and 95% confidence intervals for each GHQ-12
score, with score 0 as the reference. In addition, we did a
subgroup analysis to investigate potential reverse causality;
analyses were repeated dropping deaths within the first five
years of follow-up. This analysis did not include deaths from
external causes.
We compared people with data missing for one or more variable
with those with complete data. Covariates were compared with
Student’s t test for continuous variables and χ2 tests for
categorical variables. In the sensitivity analysis, we imputed
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missing values for covariates with Predictive Analytics Software
version 18.0,25 using five imputations. All other analyses were
conducted using R version 2.15.026 and the survival andmetafor27
packages. Figures were constructed using the Rmeta28 and gplots
packages. The reporting of this study conforms to the STROBE
statement.29
Results
The initial pooled sample included 85 261 adults. Table 1⇓
shows details of individual studies. We excluded participants
who declined linkage to mortality records (n=9325; web table
1 compares those who consented to record linkage with those
who did not); with missing GHQ-12 data (n=2532); with
baseline cardiovascular disease (n=3492), cancer (n=1511), or
both (n=159); and with no cause of death recorded or for whom
no survival time could be calculated (n=20). The final analytic
sample comprised 68 222 people (37 649 (55.2%) women) with
a mean age of 55.1 years (standard deviation 14.1, range
35-102). The composition of the sample is shown in figure 1⇓.
Table 2⇓ shows details of the study members’ baseline
characteristics. People with higher GHQ-12 scores generally
had unfavourable levels of covariates and mortality risk, apart
from being slightly younger and having a lower systolic blood
pressure than those with lower GHQ-12 scores. Participants
with the highest GHQ-12 scores were slightly less likely to
drink heavily than those with lower scores.
Of 8365 deaths during a mean follow-up of 8.2 years (standard
deviation 3.5), 3382 death certificates mentioned cardiovascular
disease, 2552 mentioned cancer, and 386 mentioned an external
cause of death. Figure 2⇓ shows the numbers of participants,
total deaths, and the number related to major causes of death.
It also provides the age and sex adjusted hazard ratio for the
relation of increased psychological distress (one standard
deviation increase in GHQ-12 score) with overall mortality,
cardiovascular disease death, cancer death, and death from
external causes for each annual cohort in addition to the totals
and overall effect frommeta-analysis. Overall, we saw increases
of 21% in age and sex adjusted risk of all cause mortality, 22%
in risk of cardiovascular disease death, 9% in risk of cancer
death, and 26% in risk of death from external causes per standard
deviation increase in GHQ-12 score. Individually, all cohorts
showed a similar effect, although the strength of the association
between GHQ-12 score and mortality was somewhat weaker
for 1997 and 2002—the reason for this is unclear. However,
when we conducted sensitivity analyses by excluding the 1997
and 2002 cohorts from pooled analyses, the hazard ratio was
unchanged. Therefore, we included participants from these
surveys in the main analyses.
Deaths from all causes
We saw a significant association, across the full range of
severity, between psychological distress and all cause mortality.
Table 3⇓ shows the results for the four categories of GHQ-12
score; even the subclinically symptomatic group (score 1-3) had
a 20% increased risk of mortality after adjusting for age and
sex. This association was essentially unchanged after adjusting
for a range of covariates that included occupational social class,
alcohol intake, and smoking. We saw strong evidence of a
dose-response effect (age and sex adjusted hazard ratio per
standard deviation disadvantage in GHQ-12 score 1.21, 95%
confidence interval 1.15 to 1.27; P<0.001 for trend). Figure 3⇓
shows the association between risk of death from all causes and
the full range of psychological distress.
Cardiovascular disease death
Focusing on cardiovascular disease death in particular showed
a similarly increased risk in association with psychological
distress, again across the full range of severity; subclinically
symptomatic patients were at a 29% increased risk of
cardiovascular disease death (table 3). This association remained
after adjustment for each covariate individually and in a model
incorporating all covariates. The magnitude of the increase in
risk in the fully adjusted model was little attenuated. Again,
there was strong evidence of a dose-response effect (age and
sex adjusted hazard ratio per standard deviation disadvantage
in GHQ-12 score 1.22, 95% confidence interval 1.14 to 1.31;
P<0.001 for trend) across the full range of GHQ-12 scores (fig
3).
Cancer deaths
Cancer death was not associated with low levels of
psychological distress in the sameway as cardiovascular disease
death (table 3). However, psychological distress in highly
symptomatic patients (GHQ-12 scores 6-12) was associated
with a 41% increased risk of cancer death. Figure 3 confirms
that this association was only present in GHQ-12 scores greater
than six. Nevertheless, we saw a significant dose-response effect
(age and sex adjusted hazard ratio per standard deviation
disadvantage in GHQ-12 score 1.09, 95% confidence interval
1.04 to 1.13; P<0.001 for trend). This association remained after
adjustment for all covariates individually and in the fully
adjustedmodel (hazard ratio per standard deviation disadvantage
in GHQ-12 score 1.05, 0.99 to 1.11, P=0.141).
Deaths from external causes
Death from external causes was also associated with
psychological distress across the full range of scores;
subclinically symptomatic patients were at a 29% increased risk
of death from external causes (table 3). This association
remained on adjustment for covariates individually and remained
unchanged in the fully adjusted model. Once again, we saw
strong evidence of a dose-response effect (age and sex adjusted
hazard ratio per standard deviation disadvantage in GHQ-12
score 1.26, 95% confidence interval 1.14 to 1.40; P<0.001 for
trend) across the full range of GHQ-12 scores (fig 3).
The population proportional attributable risk summarises the
population effect of an exposure taking into account its
prevalence. For the subclinically symptomatic category of
psychological distress, the proportional attributable risk was
3.8% for overall mortality (fully adjusted hazard ratio 1.16),
5.8% for cardiovascular disease mortality (1.25), −1.2% for
cancer mortality (0.95), and 5.4% for deaths from external
causes (1.23).
Sensitivity analysis
Data were missing for one or more variables in 39.4% (n=26
860) of the sample. People with missing data were older and
were more likely to be female, be overweight, have lower blood
pressure, be less active, not smoke, drink alcohol within
recommended limits, and have diabetes at baseline. However,
they were nomore likely to belong to a non-manual occupational
social class (web table 2). Therefore, participants with missing
data did not always have unfavourable levels of risk factors.
Accounting for missing data by multiple imputation did not
alter the effect sizes found (table 4⇓).
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Subgroup analyses
We excluded deaths occurring within the first five years of
follow-up to examine reverse causality. This subgroup analysis
slightly attenuated the effect size for the association between
psychological distress and all cause mortality (age and sex
adjusted hazard ratio per standard deviation disadvantage in
GHQ-12 score [all data] 1.21, 95% confidence interval 1.15 to
1.27, P<0.001 v 1.13, 1.10 to 1.17, P<0.001) and cardiovascular
disease death (web table 3). The association with cancer deaths
was further attenuated towards the null by excluding deaths
within the first five years of follow-up (web table 3). Comparing
a narrow case definition (that the condition was the underlying
cause of death) and a broad case definition (that any mention
of the condition on the death certificate was sufficient) had
essentially no effect on the results (web table 4).
Discussion
The main finding of this study was a dose-response association
between psychological distress and mortality from all causes,
cardiovascular disease, and external causes across the full range
of distress, even in people who would not usually come to the
attention of mental health services. A similar association with
cancer was only seen at higher levels of psychological distress.
These associations remained after adjustment for age, sex,
current occupational social class, body mass index, systolic
blood pressure, physical activity, smoking, alcohol consumption,
and diabetes. The associations with deaths from all causes,
cardiovascular disease, and cancer remained after deaths in the
first five years of follow-up were excluded.
Study strengths and limitations
This study is the first to use an individual participant
meta-analysis methodology to examine the association between
a psychological variable and mortality. It used a very large
sample of the general population, and over 8000 participants
died during follow-up. This large sample size provides sufficient
power to allow detailed analyses to be conducted and reverse
causality to be investigated. The cohort participants were well
characterised, allowing relevant contextual variables to be
incorporated into the statistical models, although the possibility
of residual confounding remains.
UsingGHQ-12 score to estimate psychological distress, although
widely used in population based studies,18 is not without
limitations. The scale itself, with non-specific questions about
feelings of unhappiness and confidence, worry, and feelings of
worthlessness, does not provide a clinical diagnosis of anxiety
or depression, even though the 12 items do capture several
diagnostic criteria in ICD-10 or the Diagnostic and Statistical
Manual of Mental Disorders, fourth edition. However, there is
evidence that screening positive on the GHQ-12, defined here
as scores of 4 or more, is associated with anxiety and
depression.20 21GHQ-12 has been shown to be a valid screening
tool for anxiety and depression diagnosed according to the
Diagnostic and Statistical Manual of Mental Disorders, third
edition (revised).30
Classifying cause of death according to death certification is a
commonmethodology in epidemiological studies. Since causes
of death are based on the certifying doctor’s clinical assessment
and knowledge of the deceased person, they may not always be
perfectly accurate, but it is likely that the broad causes of death
(for example, cardiovascular disease and cancer) used in the
present study were sufficiently valid. The only study in the
United Kingdom comparing death certification, with about 60
autopsy findings,31 found that cardiac disease was correctly
recorded on death certificates in all 21 cases and neoplastic
disease was correctly recorded in 14 of 18 cases. Elsewhere, in
Norway, analyses of 1140 autopsies showed that death
certification of stroke and ischaemic heart disease was
satisfactory for the purposes of epidemiological research.32
Another limitation in the current study was the relatively large
number of participants with data missing for one or more
variables. The differences between those with and without
missing data, detailed above, were all highly significant, apart
from current occupational social class. However, statistical
significance was partly achieved as a result of the large sample
size and the absolute differences are small and unlikely to be
clinically significant. People with missing data were not always
at an increased risk of mortality. Indeed, the sensitivity analysis
using multiple multivariate imputation techniques did not alter
the effect sizes reported; thus, bias resulting from the missing
data was unlikely.
The diminishing magnitude of association between
psychological distress and mortality with increasing duration
of follow-up shown in figure 2 may reflect reverse causality.
That is, undiagnosed somatic illness will be associated with
both an increased prevalence of psychological distress and an
increased risk of mortality. The effect of hidden somatic illness
will diminish with increasing duration of follow-up as people
with such conditions die, potentially resulting in the trend seen
in figure 2. One specific criticism of many prospective studies
considering depression as a causal factor in cardiovascular
disease is that subclinical atherosclerosis is not controlled for,33
and persistent depressive symptoms have been shown to be
associated with coronary atherosclerosis.34 While the current
study did not have any direct measures of atherosclerosis, we
excluded patients with overt cardiovascular disease at baseline
and further exclusion of deaths within five years of follow-up
reduced the possibility that our findings were driven by
subclinical disease.
Comparison with other studies
One study of 4501 adults in primary care reported a
dose-response association between psychological distress
(measured by the GHQ-12) and overall mortality (366 deaths;
GHQ-12 score 1-3: hazard ratio 1.38, 95% confidence interval
1.06 to 1.79; score 4-12: 1.71, 1.32 to 2.23), mainly due to
ischaemic heart disease and respiratory diseases.2 A smaller
study (n=923) found a 16% increase in mortality per point
increase in GHQ-12 score, mainly in men (hazard ratio 1.16,
1.07 to 1.25, P<0.001).35 The Framingham Heart Study found
a direct association between depressive symptoms and all cause
mortality in 3634 people (hazard ratio per tertile increment on
the Center for Epidemiologic Studies depression scale 1.37,
95% confidence interval 1.10 to 1.71; P=0.005 for trend).36 In
the Whitehall II study of 10 000 British civil servants,
psychological distress, measured by a 30 item GHQ scale, was
not associated with death from all cause mortality (355 deaths).37
Therefore, the present study is the largest so far to show a
dose-response relation between psychological distress and
mortality.
The association between depression and mortality is less clear
in later life, but the association remains even with adjustment
for cognitive and functional impairment and social support.
However, the association seems to disappear when people are
followed up over long periods.37-39 This finding is consistent
with our data because the effect estimates were smallest in
participants with the longest follow-up period (the earliest
surveys) compared with those with shorter follow-up (more
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recent surveys; fig 2). Asmentioned above, this differencemight
relate to dilution of the effect of undiagnosed somatic illness at
baseline. Changes in psychological distress during the follow-up
could have attenuated associations with mortality.
As described, prospective studies investigating the association
between psychological distress and cardiovascular disease have
also generally been small and therefore underpowered, none
reporting more than several hundred cardiovascular
events.2 4 9 40-42 However, they all found an increased risk of
cardiovascular disease, one reporting a dose-response association
(137 deaths from all circulatory disease; hazard ratios 1.42 and
1.66 for GHQ-12 scores 1-3 and 4-12, respectively).2 A study
looking at phobic anxiety found an age adjusted relative risk of
fatal coronary heart disease of 3.01 (n=40).34 A meta-analysis
of 21 studies investigating the association between depressive
symptoms and coronary heart disease incidence found a pooled
relative risk of 1.81, similar for fatal and non-fatal outcomes
but greater for clinically diagnosed depression than depressive
symptoms.6 A recent meta-analysis showed a pooled adjusted
hazard ratio of 1.45 (95% confidence interval 1.29 to 1.63) for
depression and stroke.43 These effect estimates are similar to
most published studies investigating depression or depressive
symptoms as aetiological risk factors for cardiovascular disease,
which generally report a relative risk of 1.5 to 2, though the
Whitehall II study only identified an association in men.42 The
results of the current study, using cardiovascular disease death
as the outcome of interest, are comparable to the results of this
recent meta-analysis.43
One large retrospective study found a risk ratio of 1.39 for
myocardial infarction in 12 304 participants with depression.44
However, the absence of data for the presence of prevalent
cardiovascular disease at baseline is an important limitation,
particularly by comparison with the extensive baseline
assessment in the Health Survey for England.
Distress in general is sometimes dismissed as a reaction to the
diagnosis of a serious physical illness. In the present study,
excluding deaths in the first five years of follow-up attenuated
the association between psychological distress and cancer
mortality, suggesting that this might partly explain the
association. However, a meta-analysis of 165 studies found an
association between stress related psychological factors and
cancer incidence in healthy people (P=0.005).7 In addition,
chronic and severe depression is possibly associated with cancer
incidence ,with a stronger association generally found with
disease progression.33
Mechanism of effect
The mechanism of the association between psychological
distress and mortality might be direct or indirect. A direct effect
could be a physiological change associated with an increased
risk of death. For example, acute psychological stress does alter
cardiovascular physiology and is associated with transient
myocardial ischaemia even in the absence of disease.3
Furthermore, both psychological stress and depression could
lead to dysregulation of the hypothalamic-pituitary-adrenal axis,
resulting in a modest increase in inflammatory markers and
cortisol release.45 Depressive symptoms are associated with
altered autonomic functioning, such as 3-methoxy-phenylglycol
(a major metabolite of noradrenaline) response to stressors.41
Depressive symptoms are also associated with increased levels
of inflammatory markers, including C reactive protein,9
interleukin 6, and tumour necrosis factor α.45 Antidepressant
drugs have been shown to suppress the inflammatory response,45
but use of these substances has been associated with increased
systemic inflammation independent of comorbidity46 and
increased cardiovascular disease.47 General population surveys
show that about 3.7% of patients will have taken an
antidepressant during the past year.48 Therefore, it is unlikely
that antidepressant use alone can explain the increased risk of
mortality found with psychological distress.
Psychiatric illness is associated with increased mortality,49 and
part of this association could be mediated by behavioural and
lifestyle factors,50 including physical inactivity and smoking.
However, we were able to incorporate many of the important
behavioural and lifestyle factors into the models in the current
study, and the association between psychological distress and
mortality remained highly significant, suggesting that indirect
mechanisms are unlikely to completely explain this association.
Implications
Depression is a serious and debilitating disorder requiring
treatment in its own right, but the finding that any level of
psychological distress is associated with increased mortality
and an increased risk of death from cardiovascular disease,
external causes, and cancer (albeit only at higher levels of
distress) is highly important. Furthermore, only two studies,
much smaller than the present study, have previously
demonstrated a dose-response relation between psychological
distress and all cause35 or cardiovascular disease mortality,2with
other studies having compared presence and absence of
psychological distress.4 9 40-42 46However, due to its large sample
size, the present study was able to offer detailed insight into
this dose-response relation. All participants with any
psychological distress, even those with low GHQ-12 scores
(and therefore considered subclinically symptomatic), were at
an increased risk of mortality from all causes, cardiovascular
disease, and external causes. The association between
psychological distress and cancer was not present in
subclinically symptomatic patients. One study has identified
that different aspects of distress (depression, apathy or anergia,
and anxiety measured by the 30 item GHQ) have differential
effects on causes of death.46
While the association between psychological distress and
mortality has attracted a great deal of attention, little evidence
indicates favourable effects, in terms of mortality, with
treatment. Trial evidence has not suggested that treating
depression decreases mortality in patients with existing
cardiovascular disease,51-53 but evidence from the current study
of the increased risk associated with even low levels of
psychological distress in the general population suggests that
the overall picture may be more complex. Further research is
required to investigate whether treating psychological distress,
including overt depression or different aspects of distress, could
have an ameliorating effect on the increased mortality
demonstrated here.
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What is already known on this topic
Evidence indicates an association between symptoms of depression and anxiety (commonly referred to as psychological distress) and
mortality from various major causes
However, previous studies have been underpowered and unable to reliably ascertain thresholds of risk
What this study adds
A dose-response association exists between psychological distress and major causes of mortality across the full range of distress
That a considerably raised risk of mortality was evident, even at low levels of psychological distress, should prompt research into whether
treatment can modify this increased risk
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Tables
Table 1| Characteristics of participants* according to individual cohort studies
Year
Overall2004200320022001200019991998199719951994
—72737474757674767877Household
response (%)
—66666767687069717371Estimated adult
interview response
(%)
85 261504910 887539911 2838684552211 058587510 90510 599No of participants
Age (years)
56.9 (15.0)57.0 (14.3)56.3 (14.3)55.4 (14.4)56.0 (14.3)65.8 (18.5)55.7 (14.3)56.1 (14.3)55.6 (14.0)56.2 (14.3)56.1 (14.4)Mean (SD)
35-10735-9635-9735-9735-9735-10735-9635-9735-9535-10035-97Range
47 669
(55.9)
2910 (57.6)6056 (55.6)3041 (56.3)6267 (55.5)5389 (62.1)2998 (54.3)6079 (55.0)3208 (54.6)5897 (54.1)5824 (54.9)Female
45 243
(55.8)
2925 (59.5)6090 (57.4)3034 (57.7)6191 (56.3)3548 (55.7)3030 (56.1)5865 (54.3)3125 (54.3)5880 (55.1)5555 (53.5)Non-manual
occupational social
class†
18 550
(22.0)
971 (19.3)2305 (21.2)1215 (22.5)2431 (21.6)1428 (17.7)1245 (22.6)2564 (23.2)1369 (23.3)2528 (23.2)2494 (23.5)Current smoker
13 340
(19.8)
—§—§1109 (20.6)2391 (21.2)1134 (16.5)1053 (19.2)2354 (21.3)1175 (20.1)2132 (19.6)1992 (18.8)Drinks more than
recommended
alcohol limit‡
4249 (5.0)226 (4.5)482 (4.4)225 (4.2)566 (5.0)661 (7.6)271 (4.9)500 (4.5)265 (4.5)547 (5.0)506 (4.8)Cardiovascular
disease¶ at
baseline
3248 (3.8)277 (5.5)517 (4.7)221 (4.1)483 (4.3)405 (4.7)206 (3.7)335 (3.0)203 (3.5)324 (3.0)277 (2.6)Diabetes, including
hyperglycaemia, at
baseline
1.5 (2.7)1.3 (2.6)1.3 (2.5)1.6 (2.7)1.3 (2.5)1.6 (2.8)1.7 (2.8)1.5 (2.7)1.5 (2.7)1.7 (2.8)1.5 (2.6)GHQ-12 score
(mean (SD))
75 936
(89.1)
4316 (85.5)9494 (87.2)4774 (88.4)9972 (88.4)5926 (68.2)5177 (93.8)10 454
(94.5)
5529 (94.1)10 199
(93.5)
10 095
(95.2)
Consented to
mortality linkage
8.2 (3.5)3.5 (0.4)4.5 (0.6)5.4 (0.8)6.4 (1.0)6.8 (1.9)8.1 (1.6)9.0 (1.8)9.9 (2.1)11.5 (2.8)12.3 (3.2)Follow-up (years,
mean (SD))
8365100335250630987520120670017641873Deaths from any
cause (no)
338243125109241391209480270719795Cardiovascular
disease deaths
(no)**
25523010686211194176401217574557Total cancer deaths
(no)
3865231944471964296868Deaths from
external causes
(no)
Data are no (%) of participants unless stated otherwise. Any discrepancies in percentages are due to missing data. SD=standard deviation.
*Table represents all participants in the surveys, irrespective of consent to mortality linkage. All subsequent tables and figures represent only participants who
consented to linkage and were therefore included in the present study.
†Non-manual occupational social class comprises professional, managerial or technical, and skilled non-manual classes (I-IIINM) according to the Registrar
General classification.
‡Calculated using sex specific safe limits: ≤14 units per week for women and ≤21 units per week for men.
§In 2003 and 2004, alcohol intake was recorded in a different format to other years in the Health Surveys for England.
¶Including angina, myocardial infarction, and haemorrhagic or thrombotic stroke.
**Total deaths caused by cardiovascular disease, comprising ischaemic heart disease, cerebrovascular disease, peripheral vascular disease, and heart failure.
No commercial reuse: See rights and reprints http://www.bmj.com/permissions Subscribe: http://www.bmj.com/subscribe
BMJ 2012;345:e4933 doi: 10.1136/bmj.e4933 (Published 31 July 2012) Page 8 of 14
RESEARCH
Table 2| Baseline characteristics of study participants according to GHQ-12 score
Total noGHQ-12 category (score)
Highly symptomatic
(7-12)
Symptomatic (4-6)Subclinically
symptomatic (1-3)
Asymptomatic (0)
68 2224733520116 76041 528No of participants
68 2223024 (63.9)3209 (61.7)9680 (57.8)21 736 (52.3)Female
68 22253.3 (14.1)54.6 (14.9)55.3 (14.7)55.2 (13.7)Age (mean (SD))
66 8342476 (53.7)2806 (55.7)9436 (57.6)23 595 (57.8)Non-manual occupational social
class*
62 64027.1 (5.4)27.2 (5.0)27.1 (4.8)27.1 (4.5)Body mass index (mean (SD))
52 224134.2 (19.7)135.3 (20.7)136.9 (20.6)137.8 (20.4)Systolic blood pressure† (mm
Hg, mean (SD))
68 2222868 (60.6)3344 (64.3)10 957 (65.4)28 215 (67.9)Physical activity‡
68 1911489 (31.5)1350 (26.0)3890 (23.2)8657 (20.9)Current smoker
55 796759 (19.1)847 (19.3)2883 (20.5)7172 (21.5)Drinks more than
recommended alcohol limit§
68 222185 (3.9)203 (3.9)574 (3.4)1172 (2.8)Diabetes (including
hyperglycaemia)
Data are no (%) of participants unless stated otherwise. Any discrepancies in percentages are due to missing data. SD=standard deviation.
*Non-manual occupational social class comprises professional, managerial or technical, and skilled non-manual classes (I-IIINM) according to the Registrar General
classification.
†Mean of second and third readings.
‡Binary variable: any weekly moderate to vigorous physical activity.
§Calculated using sex specific safe limits: ≤14 units per week for women and ≤21 units per week for men.
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Table 3| Association between psychological distress and cause specific mortality
P for trend1 standard
deviation
GHQ-12 scoreParticipants
(no)
Deaths
(no)
Model
7-124-61-30
disadvantage in
GHQ-12 score*
Total mortality
<0.0011.21 (1.15 to 1.27)1.94 (1.66 to 2.26)1.43 (1.31 to 1.56)1.20 (1.13 to 1.27)1 (reference)68 2228365Age and sex
adjusted
<0.0011.16 (1.12 to 1.20)1.67 (1.41 to 2.00)1.37 (1.23 to 1.51)1.16 (1.08 to 1.24)141 3624963Fully adjusted†
Cardiovascular disease‡ mortality
<0.0011.22 (1.14 to 1.31)2.05 (1.57 to 2.70)1.44 (1.27 to 1.62)1.29 (1.17 to 1.43)1 (reference)68 2223382Age and sex
adjusted
<0.0011.17 (1.12 to 1.22)1.72 (1.44 to 2.06)1.45 (1.23 to 1.71)1.25 (1.08 to 1.44)141 3621956Fully adjusted†
Cancer mortality
<0.0011.09 (1.04 to 1.13)1.41 (1.22 to 1.64)1.07 (0.89 to 1.29)0.92 (0.84 to 1.01)1 (reference)68 2222552Age and sex
adjusted
0.1411.05 (0.99 to 1.11)1.29 (1.04 to 1.61)1.05 (0.85 to 1.30)0.95 (0.85 to 1.07)141 3621698Fully adjusted†
External cause mortality
<0.0011.26 (1.14 to 1.40)2.34 (1.52 to 3.60)1.93 (1.31 to 2.83)1.29 (1.01 to 1.65)1 (reference)68 222386Age and sex
adjusted
0.0011.32 (1.13 to 1.55)3.19 (1.78 to 5.70)2.07 (1.33 to 3.21)1.23 (0.90 to 1.70)141 362241Fully adjusted†
Data are hazard ratio (95% confidence interval) unless indicated otherwise.
*GHQ-12 score standardised with sex specific standard deviations.
†Model adjusted for age, sex, occupational social class, diabetes, body mass index, systolic blood pressure, physical activity, smoking, and alcohol consumption.
‡Cardiovascular disease comprises ischaemic heart disease, stroke, peripheral vascular disease, and heart failure.
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Table 4| Sensitivity analysis of association between psychological distress and cause specific mortality, with andwithout multiple imputation
Multiple imputationMeta-analysis
Fully adjusted
model* by cause
of death
1 standard deviation
disadvantage in
GHQ-12 score†
Participants (no)‡Deaths (no)1 standard deviation
disadvantage in
GHQ-12 score†
Participants (no)Deaths (no)
1.15 (1.13 to 1.18)57 86184921.16 (1.12 to 1.20)41 3624963Total
1.14 (1.10 to 1.19)57 86134401.17 (1.12 to 1.22)41 3621956Cardiovascular
disease§
1.05 (1.01 to 1.09)57 86125300.95 (0.85 to 1.07)41 3621698Cancer
1.23 (1.11 to 1.36)57 8613811.32 (1.13 to 1.55)41 362241External cause
Data are hazard ratio (95% confidence interval) unless indicated otherwise.
*Model adjusted for age, sex, occupational social class, diabetes, body mass index, systolic blood pressure, physical activity, smoking, and alcohol consumption.
†GHQ-12 score standardised with sex specific standard deviations.
‡Total no of participants in multiple imputation models excludes the 2003 and 2004 cohort studies since they were excluded from all fully adjusted models owing
to their recording of alcohol consumption in a different format to other years.
§Cardiovascular disease comprises ischaemic heart disease, stroke, peripheral vascular disease, and heart failure.
No commercial reuse: See rights and reprints http://www.bmj.com/permissions Subscribe: http://www.bmj.com/subscribe
BMJ 2012;345:e4933 doi: 10.1136/bmj.e4933 (Published 31 July 2012) Page 11 of 14
RESEARCH
Figures
Fig 1 Flow chart of participants from initial pooled sample to analytic sample showing subsequent mortality
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Fig 2Number of participants, total mortality, and deaths plus age and sex adjusted hazard ratios (95% confidence intervals)
per standard deviation disadvantage in GHQ-12 score, by survey year and cause of death
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Fig 3 Association between psychological distress (GHQ-12 score) and risk of cause specific death (age and sex adjusted
hazard ratio (95% confidence interval)). Reference=GHQ-12 score 0; higher GHQ-12 score indicates greater distress
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